Estrogen receptor beta expression and prognosis of diffuse large B cell lymphoma

References

• Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107:265–276. doi: 10.1182/blood-2005-06-2508
   PubMed Web of Science ®Google Scholar
• Nelson RA, Levine AM, Bernstein L., et al. Reproductive factors and risk of intermediate- or high-grade B-cell non-Hodgkin’s lymphoma in women. J Clin Oncol. 2001;19:1381–1387 doi: 10.1200/JCO.2001.19.5.1381
   PubMed Web of Science ®Google Scholar
• Lee JS, Bracci PM, Holly EA. Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use. Am J Epidemiol. 2008;168:278–288. doi: 10.1093/aje/kwn119
   PubMed Web of Science ®Google Scholar
• Lu Y, Wang SS, Sullivan-Halley J, et al. Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California teachers study. Int J Cancer. 2011;129:974–982 doi: 10.1002/ijc.25730
   PubMed Web of Science ®Google Scholar
• Kane EV, Roman E, Becker N, et al. Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies. Ann Oncol. 2012;23:2362–2374 doi: 10.1093/annonc/mds171
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Vachon CM, Habermann TM, et al. Hormone replacement therapy and risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev. 2002;11:1466–1471
   PubMed Web of Science ®Google Scholar
• Costas L, de Sanjosé S, Infante-Rivard C., et al. Reproductive factors and non-Hodgkin lymphoma: a systematic review. Crit Rev Oncol Hematol. 2014;92:181–193 doi: 10.1016/j.critrevonc.2014.07.004
   PubMed Web of Science ®Google Scholar
• Ladikou EE, Kassi E. The emerging role of estrogen in B cell malignancies. Leuk Lymphoma. 2017;58:528–539. doi: 10.1080/10428194.2016.1213828
   PubMed Web of Science ®Google Scholar
• Yakimchuk K, Jondal M, Okret S. Estrogen receptor α and β in the normal immune system and in lymphoid malignancies. Mol Cell Endocrinol. 2013;375:121–129. doi: 10.1016/j.mce.2013.05.016
   PubMed Web of Science ®Google Scholar
• Meyers MJ, Sun J, Carlson KE, et al. Estrogen receptor-β potency-selective ligands: structure−activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem. 2001;44:4230–4251. doi: 10.1021/jm010254a
   PubMed Web of Science ®Google Scholar
• Sun J, Baudry J, Katzenellenbogen JA, et al. Molecular basis for the subtype discrimination of the estrogen receptor-β-selective ligand, diarylpropionitrile. Mol Endocrinol. 2003;17:247–258. doi: 10.1210/me.2002-0341
   PubMedGoogle Scholar
• Yakimchuk K, Iravani M, Hasni MS, et al. Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo. Leukemia. 2011;25:1103–1110. doi: 10.1038/leu.2011.68
   PubMed Web of Science ®Google Scholar
• Yakimchuk K, Norin S, Kimby E, et al. Up-regulated estrogen receptor β2 in chronic lymphocytic leukemia. Leuk Lymphoma. 2012;53:139–144. doi: 10.3109/10428194.2011.605187
   PubMed Web of Science ®Google Scholar
• Talaber G, Yakimchuk K, Guan J, et al. Inhibition of estrogen biosynthesis enhances lymphoma growth in mice. Oncotarget 2016;7:20718–20727. doi: 10.18632/oncotarget.7843
   PubMed Web of Science ®Google Scholar
• Yakimchuk K, Hasni MS, Guan J, et al. Inhibition of lymphoma vascularization and dissemination by estrogen receptor β agonists. Blood. 2014;123:2054–2061. doi: 10.1182/blood-2013-07-517292
   PubMed Web of Science ®Google Scholar
• Roemer K, Pfreundschuh M. How do estrogens control lymphoma? Blood. 2014;123:1980–1981. doi: 10.1182/blood-2014-02-554691
   PubMed Web of Science ®Google Scholar
• Hasni MS, Berglund M, Yakimchuk K, et al. Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker. Leuk Lymphoma. 2017;58:418–427. doi: 10.1080/10428194.2016.1193853
   PubMed Web of Science ®Google Scholar
• Phiel KL, Henderson RA, Adelman SJ, et al. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett. 2005;97:107–113. doi: 10.1016/j.imlet.2004.10.007
   PubMed Web of Science ®Google Scholar
• Taylor SE, Martin-Hirsch PL, Martin FL. Oestrogen receptor splice variants in the pathogenesis of disease. Cancer Lett. 2010;288:133–148. doi: 10.1016/j.canlet.2009.06.017
   PubMed Web of Science ®Google Scholar
• The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 1993;329:987–994. doi: 10.1056/NEJM199309303291402
   PubMed Web of Science ®Google Scholar
• Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–282. doi: 10.1182/blood-2003-05-1545
   PubMed Web of Science ®Google Scholar
• Aukema SM, Siebert R, Schuuring E, et al. Double-hit B-cell lymphomas. Blood. 2011;117:2319–2331. doi: 10.1182/blood-2010-09-297879
   PubMed Web of Science ®Google Scholar
• Sarkozy C, Traverse-Glehen A, Coiffier B. Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. Lancet Oncol 2015;16:e555–e567. doi: 10.1016/S1470-2045(15)00005-4
   PubMedGoogle Scholar
• Al-Humood SA, Al-Qallaf AS, Alshemmari SH, et al. Genotypic and phenotypic differences between nodal and extranodal diffuse large B-cell lymphomas. J Histochem Cytochem. 2011;59:918–931. doi: 10.1369/0022155411417309
   PubMed Web of Science ®Google Scholar
• Jehan Z, Siraj AK, Abubaker J, et al. Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma. Oncology. 2008;75:71–80. doi: 10.1159/000155144
   PubMed Web of Science ®Google Scholar
• Lenz G, Wright G, Dave SS, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008;359:2313–2323. doi: 10.1056/NEJMoa0802885
   PubMed Web of Science ®Google Scholar
• Hartman J, Edvardsson K, Lindberg K, et al. Tumor repressive functions of estrogen receptor in SW480 colon cancer cells. Cancer Res 2009;69:6100–6106. doi: 10.1158/0008-5472.CAN-09-0506
   PubMed Web of Science ®Google Scholar
• Li H, Tu Z, An L, et al. Inhibitory effects of ERβ on proliferation, invasion, and tumor formation of MCF-7 breast cancer cells – prognostication for the use of ERβ-selective therapy. Pharm Biol. 2012;50:839–849. doi: 10.3109/13880209.2011.637506
   PubMed Web of Science ®Google Scholar
• Tu Z, Ma Y, Tian J, et al. Estrogen receptor β potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells. J Cancer Res Clin Oncol. 2012;138:1091–1103. doi: 10.1007/s00432-011-1145-3
   PubMed Web of Science ®Google Scholar